Journal article
Integrated safety and efficacy analysis of once-daily fluticasone furoate for the treatment of asthma
Abstract
BackgroundFluticasone furoate is a once-daily inhaled corticosteroid. This report provides an overview of safety and efficacy data that support the use of once-daily fluticasone furoate 100 μg or 200 μg in adult and adolescent asthma patients.MethodsFourteen clinical studies (six Phase II and eight Phase III) were conducted as part of the fluticasone furoate global clinical development programme in asthma. Safety data from 10 parallel-group, …
Authors
O’Byrne PM; Jacques L; Goldfrad C; Kwon N; Perrio M; Yates LJ; Busse WW
Journal
Respiratory Research, Vol. 17, No. 1,
Publisher
Springer Nature
Publication Date
12 2016
DOI
10.1186/s12931-016-0473-x
ISSN
1465-9921